Quantcast
Saturday, November 2, 2024

Biden, Fauci Tied to Monkeypox Vax-Creator

(Jim Luksic, Headline USA) Is it monkeypox or money pockets? A University of Pennsylvania document stated that President Joe Biden’s host institution was paid for assisting Bavarian Nordic in creating the MVA/BN monkeypox vaccine. 

What’s more, the business compensated Biden and Penn Biden Center (his think tank), while American taxpayers funded the vaccines and Bavarian Nordic, according to National File.

The 2014 document stated, in part: “The University of Pennsylvania is being paid by Bavarian Nordic.” The paperwork, which is filed at the Philadelphia school’s hospital and titled Consent to Participate in a Research Study and Research Subject HIPAA Authorization, refers to conducting a “Randomized open-label Phase II” clinical trial.

In 2017, Biden and UPenn joined forces; since then, the report stated, U.S. taxpayers have shelled out more than $100 million for the monkeypox cause, no thanks to President Biden’s administration literally passing the buck.

In addition, roughly $100 million was used by Dr. Anthony Fauci to fund Bavarian Nordic for what’s called the Jynneos monkeypox vaccine.

The University of Pennsylvania receives “massive” kickbacks, in conjunction with BioNtech, a partner of multinational pharmaceutical corporation Pfizer, the National File reported.

Indeed, middle-class working Americans are stuck with footing the bill for monkeypox, one of three viruses – along with COVID and bird flu (avian influenza) – that globalists are using ostensibly to satiate their greed.

In fact, “the same institute that likely created the SARS-Cov-2 virus by modifying bat viruses has now modified the Asian lineage avian influenza-A virus to be more readily transmissible and substantially more lethal,” Legal Insurrection reported.

Earlier this week, former President Donald Trump speculated that monkeypox could be another way for Democrats to justify utilizing “fake” mail-in ballots during an election year.

Copyright 2024. No part of this site may be reproduced in whole or in part in any manner other than RSS without the permission of the copyright owner. Distribution via RSS is subject to our RSS Terms of Service and is strictly enforced. To inquire about licensing our content, use the contact form at https://headlineusa.com/advertising.
- Advertisement -

TRENDING NOW

TRENDING NOW